San Diego, CA, United States of America

Thong X Nguyen

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Califia Bio, Inc., University of Rochester. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thong X Nguyen. Retrieved from https://idiyas.com/inventor/thong-x-nguyen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thong X Nguyen: Innovator in Mixed Lineage Kinase Inhibitors

Introduction

Thong X Nguyen is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medicinal chemistry, particularly in the development of mixed lineage kinase inhibitors. His work focuses on creating compounds that have therapeutic applications, showcasing his dedication to advancing medical science.

Latest Patents

Thong X Nguyen holds a patent for "Mixed lineage kinase inhibitors and method of treatments." This patent includes imidazopyridine compounds that exhibit an inhibitory effect on mixed lineage kinases (MLKs). The patent details methods for synthesizing these compounds and their therapeutic applications. Additionally, it encompasses pharmaceutical compositions that utilize these compounds, highlighting their potential in medical treatments.

Career Highlights

Throughout his career, Thong X Nguyen has worked with prominent organizations, including Califia Bio, Inc. and the University of Rochester. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Thong X Nguyen has collaborated with notable colleagues such as Val S Goodfellow and Satheesh Babu Ravula. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Thong X Nguyen's work in developing mixed lineage kinase inhibitors represents a significant advancement in therapeutic methods. His contributions to medicinal chemistry continue to influence the field and pave the way for future innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…